183 related articles for article (PubMed ID: 18971831)
21. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival.
Cerfolio RJ; Bryant AS; Jones VL; Cerfolio RM
Eur J Cardiothorac Surg; 2009 Apr; 35(4):718-23; discussion 723. PubMed ID: 19233668
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy].
El Sharouni SY; Aerts JG; Senan S; De Ruysscher DK; Groen HJ; Paul MA; Smit EF; Vonk EJ; Verhagen AF; Schramel FM
Ned Tijdschr Geneeskd; 2008 Dec; 152(50):2714-7. PubMed ID: 19192584
[TBL] [Abstract][Full Text] [Related]
24. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
[TBL] [Abstract][Full Text] [Related]
25. Surgery after induction chemoradiotherapy for non small cell lung cancer: when and why.
Koletsis EN; Prokakis C; Apostolakis E; Chatzimichalis A; Dougenis D
J BUON; 2007; 12(4):453-61. PubMed ID: 18067202
[TBL] [Abstract][Full Text] [Related]
26. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
[TBL] [Abstract][Full Text] [Related]
27. Preoperative chemotherapy in early-stage (stage IB-IIIA) resectable non small cell lung cancer. Is it justified?
Prokakis Ch; Koletsis EN; Apostolakis E; Chatzimichalis A; Dougenis D
J BUON; 2008; 13(2):161-8. PubMed ID: 18555460
[TBL] [Abstract][Full Text] [Related]
28. Which patients with stage III non-small cell lung cancer should undergo surgical resection?
Patel V; Shrager JB
Oncologist; 2005 May; 10(5):335-44. PubMed ID: 15851792
[TBL] [Abstract][Full Text] [Related]
29. Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?
Ratto GB; Costa R; Maineri P; Alloisio A; Bruzzi P; Dozin B
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):849-58. PubMed ID: 19660370
[TBL] [Abstract][Full Text] [Related]
30. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
31. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
van Meerbeeck JP; Surmont VF
Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
[TBL] [Abstract][Full Text] [Related]
32. Role of surgery in N2 NSCLC: pros.
Shien K; Toyooka S
Jpn J Clin Oncol; 2016 Dec; 46(12):1168-1173. PubMed ID: 27655902
[TBL] [Abstract][Full Text] [Related]
33. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
[TBL] [Abstract][Full Text] [Related]
34. Restaging of the mediastinum.
Herth FJ; Ernst A; Eberhardt R
Curr Opin Pulm Med; 2009 Jul; 15(4):308-12. PubMed ID: 19436205
[TBL] [Abstract][Full Text] [Related]
35. Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.
Tell R; Sederholm C; Klintenberg C; Franksson L; Brandén E; Hillerdal G; Lönn U; Lindén CJ; Ewers SB; Lamberg K; Mrazek E; Lödén B; Sjögren A; Linné T; Friesland S; Sirzén F
Anticancer Res; 2008; 28(5B):2851-7. PubMed ID: 19031924
[TBL] [Abstract][Full Text] [Related]
36. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
[TBL] [Abstract][Full Text] [Related]
37. Survival of patients with true pathologic stage I non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
[TBL] [Abstract][Full Text] [Related]
38. Postoperative radiation therapy for non-small cell lung cancer.
Decker RH; Wilson LD
Semin Thorac Cardiovasc Surg; 2008; 20(3):184-7. PubMed ID: 19038726
[TBL] [Abstract][Full Text] [Related]
39. Treatment of locally advanced non-small cell lung cancer.
Fidler MJ; Kim AW; Zusag T; Bonomi P
Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance and possibility in guiding adjuvant therapy of the pleural lavage cytology in patients with non-small cell lung cancer.
Nakamura T; Suzuki K; Mochizuki T; Ohde Y; Kobayashi H; Nakamura H; Toyoda F
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):321-4. PubMed ID: 19059950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
